These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 9437228
1. Influence of chronic naltrexone treatment on growth hormone secretion in normal subjects. Villa P, Valle D, De Marinis L, Mancini A, Bianchi A, Fulghesu AM, Caruso A, Mancuso S, Lanzone A. Eur J Endocrinol; 1997 Dec; 137(6):631-4. PubMed ID: 9437228 [Abstract] [Full Text] [Related]
2. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects. De Marinis L, Mancini A, Valle D, Bianchi A, De Luca AM, Fulghesu AM, Villa P, Mancuso S, Lanzone A. Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1076-81. PubMed ID: 9368834 [Abstract] [Full Text] [Related]
3. Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients. Villa P, Fulghesu AM, De Marinis L, Valle D, Mancini A, Pavone V, Caruso A, Lanzone A. Metabolism; 1997 May; 46(5):538-43. PubMed ID: 9160821 [Abstract] [Full Text] [Related]
4. Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation. Bondanelli M, Ambrosio MR, Margutti A, Boldrini P, Basaglia N, Franceschetti P, Zatelli MC, Degli Uberti EC. Metabolism; 2002 Oct; 51(10):1363-9. PubMed ID: 12370860 [Abstract] [Full Text] [Related]
5. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa. Gianotti L, Pincelli AI, Scacchi M, Rolla M, Bellitti D, Arvat E, Lanfranco F, Torsello A, Ghigo E, Cavagnini F, Müller EE. J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886 [Abstract] [Full Text] [Related]
6. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD. Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380 [Abstract] [Full Text] [Related]
7. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD. J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555 [Abstract] [Full Text] [Related]
12. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G. J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687 [Abstract] [Full Text] [Related]
13. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect. Rosenthal SM, Kaplan SL, Grumbach MM. J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383 [Abstract] [Full Text] [Related]
15. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR. J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841 [Abstract] [Full Text] [Related]
16. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations. Bernardi F, Petraglia F, Seppala M, Spinetti A, Bertolini S, Ferdeghini M, Genazzani AR. Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822 [Abstract] [Full Text] [Related]
17. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. Procopio M, Maccario M, Grottoli S, Oleandri SE, Boffano GM, Camanni F, Ghigo E. Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266 [Abstract] [Full Text] [Related]
18. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome. Leal-Cerro A, Povedano J, Astorga R, Gonzalez M, Silva H, Garcia-Pesquera F, Casanueva FF, Dieguez C. J Clin Endocrinol Metab; 1999 Sep; 84(9):3378-81. PubMed ID: 10487713 [Abstract] [Full Text] [Related]
19. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study. Jaffe CA, Turgeon DK, Friberg RD, Watkins PB, Barkan AL. J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445 [Abstract] [Full Text] [Related]
20. The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men. Haijma SV, van Dam PS, de Vries WR, Maitimu-Smeele I, Dieguez C, Casanueva FF, Koppeschaar HP. Eur J Endocrinol; 2005 Apr; 152(4):575-80. PubMed ID: 15817913 [Abstract] [Full Text] [Related] Page: [Next] [New Search]